Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

siRNA technology.

N Schütze1

  • 1Orthopaedic University Hospital, Molecular Orthopaedics, Brettreichstrasse 11, 97074 Würzburg, Germany. n-schuetze.zlk@mail.uni-wuerzburg.de

Molecular and Cellular Endocrinology
|April 6, 2004
PubMed
Summary

RNA interference (RNAi) is a natural genome defense mechanism utilizing short interfering RNAs (siRNAs) for precise gene silencing. This technology shows promise for developing new therapeutic strategies by targeting disease-related genes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis of periprosthetic hip infections].

Operative Orthopadie und Traumatologie·2015
Same author

Enhanced in vitro endothelial progenitor cell number by treatment with the angiogenic inducer CYR61/CCN1.

Journal of stem cells & regenerative medicine·2014
Same author

Microarray analyses and bioinformatic evaluation of the plasticity between human mesenchymal stem cell-derived osteoblasts and adipocytes.

Journal of stem cells & regenerative medicine·2014
Same author

Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.

Thrombosis and haemostasis·2013
Same author

Inhibition of endotoxin-induced perinatal asthma protection by pollutants in an experimental mouse model.

Allergy·2013
Same author

Connective tissue growth factor does not affect transforming growth factor-beta 1-induced Smad3 phosphorylation and T lymphocyte proliferation inhibition.

International archives of allergy and immunology·2008

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • RNA interference (RNAi) is a natural biological process for genome protection.
  • Short interfering RNAs (siRNAs) are key mediators of this gene silencing mechanism.
  • The field of RNAi has advanced rapidly, revealing significant therapeutic potential.

Purpose of the Study:

  • To explore the mechanism and applications of RNA interference (RNAi).
  • To highlight the role of siRNAs in gene silencing.
  • To discuss the therapeutic implications of RNAi technology.

Main Methods:

  • Utilizing short interfering RNAs (siRNAs) for targeted gene silencing.
  • Investigating in vitro and in vivo applications of siRNA technology.
  • Evaluating the efficacy of siRNA-mediated gene knock-down in disease models.

Main Results:

  • siRNAs enable highly specific and efficient targeting of genes.
  • Various methods for obtaining siRNAs facilitate diverse applications.
  • Successful knock-down of disease-related genes has been demonstrated.

Conclusions:

  • RNA interference is a powerful tool for gene regulation.
  • siRNA-based therapies offer a promising avenue for treating diseases.
  • The specificity and efficiency of siRNAs support their therapeutic use.

Related Experiment Videos